Loncastuximab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Loncastuximab Usage And Synthesis

Uses

Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab has antitumor activity and can be used in the research of Non-Hodgkin Lymphoma (NHL) and Diffuse Large B-cell Lymphoma (DLBCL)[1][2].

References

[1] Zinzani PL, et al. Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2022 Jan;148(1):177-190. DOI:10.1007/s00432-021-03833-x
[2] Hess B, et al. Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma. AAPS J. 2021 Dec 10;24(1):11. DOI:10.1208/s12248-021-00660-3

Loncastuximab(1875032-68-0)Related Product Information

• Talquetamab
• Vilobelimab
• Lomtegovimab
• Onartuzumab
• Prezalumab
• Relfovetmab
• Abelacimab
• Altumomab
• Coltuximab Ravtansine
• Felvizumab